Jaguar Health Inc. (NASDAQ: JAGX) started the day on April 30, 2021, with a price decrease of -0.66% at $1.51. During the day, the stock rose to $1.55 and sunk to $1.45 before settling in for the price of $1.52 at the close. Taking a more long-term approach, JAGX posted a 52-week range of $0.19-$4.47.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 105.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 88.90%. This publicly-traded company’s shares outstanding now amounts to $127.91 million, simultaneously with a float of $127.39 million. The organization now has a market capitalization sitting at $194.40 million. At the time of writing, stock’s 50-day Moving Average stood at $1.8896, while the 200-day Moving Average is $1.1897.
Let’s gauge the efficiency of the firm, which has a total of 34 employees. It has generated 276,029 per worker during the last fiscal year. Meanwhile, its income per employee was -994,382. The stock had 3.00 Receivables turnover and 0.24 Total Asset turnover. For the Profitability, stocks gross margin was +65.05, operating margin was -283.93 and Pretax Margin of -360.25.
Jaguar Health Inc. (JAGX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Jaguar Health Inc.’s current insider ownership accounts for 10.62%, in contrast to 5.80% institutional ownership.
Jaguar Health Inc. (JAGX) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported -$0.15 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.1) by -$0.05. This company achieved a net margin of -360.25 while generating a return on equity of -179.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
Jaguar Health Inc.’s EPS increase for this current 12-month fiscal period is 88.90% and is forecasted to reach -0.18 in the upcoming year.
Jaguar Health Inc. (NASDAQ: JAGX) Trading Performance Indicators
Let’s observe the current performance indicators for Jaguar Health Inc. (JAGX). It’s Quick Ratio in the last reported quarter now stands at 1.10. The Stock has managed to achieve an average true range (ATR) of 0.17. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 20.68.
In the same vein, JAGX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.36, a figure that is expected to reach -0.02 in the next quarter, and analysts are predicting that it will be -0.18 at the market close of one year from today.
Technical Analysis of Jaguar Health Inc. (JAGX)
If we take a close look at the recent performances of Jaguar Health Inc. (NASDAQ: JAGX), its last 5-days Average volume was 9.05 million that shows plunge from its year to date volume of 30.12 million. During the previous 9 days, stock’s Stochastic %D was recorded 67.88% While, its Average True Range was 0.1670.
Raw Stochastic average of Jaguar Health Inc. (JAGX) in the period of the previous 100 days is set at 28.67%, which indicates a major fall in contrast to 55.17% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 122.12% that was lower than 263.98% volatility it exhibited in the past 100-days period.